ImportRefusal LogoImportRefusal

Novartis Pharmaceuticals Corporation

⚠️ High Risk

FEI: 3010353512 • Morris Plains, NJ • UNITED STATES

FEI

FEI Number

3010353512

📍

Location

Morris Plains, NJ

🇺🇸
🏢

Address

220 E Hanover Ave, , Morris Plains, NJ, United States

High Risk

FDA Import Risk Assessment

50.5
LowModerateHighCritical

This firm has a significant history of FDA import refusals with notable violations.

Statistics

2
Total Refusals
1
Unique Violations
11/4/2025
Latest Refusal
11/3/2025
Earliest Refusal

Score Breakdown

Violation Severity
60.0×40%
Refusal Volume
17.7×30%
Recency
95.8×20%
Frequency
20.0×10%
How is this score calculated?

Proprietary Algorithm

  • 40% Violation Severity — AI-assessed (1-10)
  • 30% Refusal Volume — Logarithmic scale
  • 20% Recency — Decays over 5 years
  • 10% Frequency — Refusals per year

© ImportRefusal.com Original Analysis

Violation Summary

1792×

AGR RX

The article appears to be a prescription drug manufactured in the U.S. and offered for import by other than the manufacturer and reimportation does not appear to have been authorized by the Secretary for use in a medical emergency.

Refusal History

DateProductViolationsDivision
11/4/2025
58MCP25SECUKINUMAB
179AGR RX
Division of West Coast Imports (DWCI)
11/3/2025
58MCP25SECUKINUMAB
179AGR RX
Division of West Coast Imports (DWCI)

Frequently Asked Questions

What is Novartis Pharmaceuticals Corporation's FDA import refusal history?

Novartis Pharmaceuticals Corporation (FEI: 3010353512) has 2 FDA import refusal record(s) in our database, spanning from 11/3/2025 to 11/4/2025.

What is an FEI number?

FEI stands for Firm Establishment Identifier. It's a unique number assigned by the FDA to identify establishments that manufacture, process, pack, or hold food, drugs, medical devices, or other FDA-regulated products. Novartis Pharmaceuticals Corporation's FEI number is 3010353512.

What types of violations has Novartis Pharmaceuticals Corporation received?

Novartis Pharmaceuticals Corporation has been cited for 1 different violation type(s). Common FDA violations include adulteration (unsafe or unsanitary products), misbranding (incorrect or misleading labels), and regulatory non-compliance.

Where does this information about Novartis Pharmaceuticals Corporation come from?

All FDA import refusal data for Novartis Pharmaceuticals Corporation is sourced from the official FDA Data Dashboard (datadashboard.fda.gov), a public government database maintained by the U.S. Food and Drug Administration.

Data sourced from the FDA Data Dashboard, a public database maintained by the U.S. Food and Drug Administration.